Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Aug:83:106171.
doi: 10.1016/j.leukres.2019.106171. Epub 2019 Jun 15.

Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma

Dipenkumar Modi  1 , Malini Surapaneni  2 , Seongho Kim  3 , Lois Ayash  4 , Asif Alavi  5 , Voravit Ratanatharathorn  6 , Abhinav Deol  7 , Joseph P Uberti  8
Affiliations
Clinical Trial

Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma

Dipenkumar Modi et al. Leuk Res. 2019 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial disclosure

The authors have no existing or potential financial conflict of interest to disclose. No funding was obtained.

Figures

Fig. 1.
Fig. 1.
(a–c) Kaplan-Meier survival curves for overall survival (OS), relapse-free survival (RFS), and GVHD-free/relapse-free survival (GRFS). NR stands for not reached. (d–e) Cumulative incidence curves for relapse and non-relapse mortality (NRM).
See this image and copyright information in PMC

References

    1. Weisenburger DD, Savage KJ, Harris NL, et al., Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project, Blood. 117 (March (12)) (2011) 3402–3408, 10.1182/blood-2010-09-310342. - DOI - PubMed
    1. d’Amore F, Relander T, Lauritzsen GF, et al., Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01, J. Clin. Oncol 30 (September (25)) (2012) 3093–3099, 10.1200/JCO.2011.40.2719. - DOI - PubMed
    1. Reimer P, Rudiger T, Geissinger E, et al., Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study, J. Clin. Oncol 27 (January (1)) (2009) 106–113, 10.1200/JCO.2008.17.4870 - DOI - PubMed
    1. Corradini P, Tarella C, Zallio F, et al., Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation, Leukemia. 20 (September (9)) (2006) 1533–1538, 10.1038/sj.leu.2404306. - DOI - PubMed
    1. Mercadal S, Briones J, Xicoy B, et al., Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma, Ann. Oncol 19 (May (5)) (2008) 958–963, 10.1093/annonc/mdn022. - DOI - PubMed

Publication types